NAV | $32.48 | Daily Change | $0.28 | 0.87% |
Market Price | $32.59 | Daily Change | $0.34 | 1.05% |
Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.1
With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to seniors' distinct consumer preferences.
The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.
1WHO, Oct 2022
Inception Date | 05/09/16 |
Total Expense Ratio | 0.50% |
Net Assets | $63.02 million |
NAV | $32.48 |
Fact Sheet | View the document |
The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.
The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.
Ticker | AGNG |
Bloomberg Index Ticker | ILNGRNT |
CUSIP | 37954Y772 |
ISIN | US37954Y7720 |
Primary Exchange | Nasdaq |
Shares Outstanding | 1,940,000 |
Number of Holdings | 83 |
30-Day Median Bid-Ask Spread | 0.37% |
30-Day SEC Yield | 0.81% |
Distribution Frequency | Semi-Annually |
NAV | $32.48 | Daily Change | $0.28 | 0.87% |
Market Price | $32.59 | Daily Change | $0.34 | 1.05% |
As of recent month & quarter-end (09/30/24)
As of recent month & quarter-end (09/30/24)
|
Fund NAV | Market Price | Index |
---|---|---|---|
1 Year | 26.40% | 27.20% | 26.83% |
3 Years | 4.73% | 5.07% | 5.01% |
5 Years | 9.83% | 9.72% | 10.10% |
Since Inception | 10.37% | 10.67% | 10.66% |
1 Year | 26.40% | 27.20% | 26.83% |
3 Years | 4.73% | 5.07% | 5.01% |
5 Years | 9.83% | 9.72% | 10.10% |
Since Inception | 10.37% | 10.67% | 10.66% |
Year-to-Date | 15.27% | 15.84% | 15.54% |
1 Month | -1.21% | -1.03% | -1.16% |
3 Months | 8.95% | 9.14% | 9.11% |
Since Inception | 128.99% | 134.39% | 134.20% |
Year-to-Date | 15.27% | 15.84% | 15.54% |
1 Month | -1.21% | -1.03% | -1.16% |
3 Months | 8.95% | 9.14% | 9.11% |
Since Inception | 128.99% | 134.39% | 134.20% |
Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.
Net Assets (%) | Ticker | Name | SEDOL | Market Price ($) | Shares Held | Market Value ($) |
---|---|---|---|---|---|---|
4.07 | 4519 JP | CHUGAI PHARMA CO | 6196408 | 51.26 | 50,049 | 2,565,568.54 |
3.92 | WELL | WELLTOWER INC | BYVYHH4 | 130.57 | 18,936 | 2,472,473.52 |
3.34 | BSX | BOSTON SCIENTIFIC CORP | 2113434 | 84.76 | 24,856 | 2,106,794.56 |
3.20 | LLY | ELI LILLY & CO | 2516152 | 895.59 | 2,253 | 2,017,764.27 |
3.19 | AMGN | AMGEN INC | 2023607 | 317.17 | 6,337 | 2,009,906.29 |
3.14 | ALC SW | ALCON INC | BJT1GR5 | 94.89 | 20,840 | 1,977,495.41 |
3.08 | RO SW | ROCHE HOLDING AG-BR | 7108918 | 352.49 | 5,509 | 1,941,845.35 |
3.08 | UCB BB | UCB SA | 5596991 | 192.57 | 10,075 | 1,940,141.07 |
3.07 | ABBV | ABBVIE INC | B92SR70 | 189.68 | 10,214 | 1,937,391.52 |
2.99 | MDT | MEDTRONIC PLC | BTN1Y11 | 90.60 | 20,823 | 1,886,563.80 |
2.97 | AZN | ASTRAZENECA PLC-SPONS ADR | 2989044 | 76.01 | 24,637 | 1,872,658.37 |
2.95 | JNJ | JOHNSON & JOHNSON | 2475833 | 161.60 | 11,499 | 1,858,238.40 |
2.91 | BMY | BRISTOL-MYERS SQUIBB CO | 2126335 | 52.64 | 34,833 | 1,833,609.12 |
2.79 | SYK | STRYKER CORP | 2853688 | 356.01 | 4,941 | 1,759,045.41 |
2.74 | REGN | REGENERON PHARMACEUTICALS | 2730190 | 928.61 | 1,859 | 1,726,285.99 |
2.43 | NOVOB DC | NOVO NORDISK A/S-B | BP6KMJ1 | 111.78 | 13,712 | 1,532,715.96 |
2.41 | 068270 KS | CELLTRION INC | B0C5YV1 | 135.52 | 11,224 | 1,521,115.38 |
2.30 | 4543 JP | TERUMO CORP | 6885074 | 18.84 | 77,093 | 1,452,207.03 |
2.13 | VTR | VENTAS INC | 2927925 | 64.74 | 20,767 | 1,344,455.58 |
2.03 | EW | EDWARDS LIFESCIENCES CORP | 2567116 | 68.52 | 18,686 | 1,280,364.72 |
1.92 | STMN SW | STRAUMANN HOLDING AG-REG | BQ7ZV06 | 147.14 | 8,218 | 1,209,185.42 |
1.89 | SOON SW | SONOVA HOLDING AG-REG | 7156036 | 387.37 | 3,078 | 1,192,309.52 |
1.74 | ZBH | ZIMMER BIOMET HO | 2783815 | 103.60 | 10,581 | 1,096,191.60 |
1.70 | BGNE | BEIGENE LTD-ADR | BYYWPW6 | 217.22 | 4,941 | 1,073,284.02 |
1.68 | 4503 JP | ASTELLAS PHARMA INC | 6985383 | 11.33 | 93,490 | 1,058,843.57 |
1.59 | SDZ SW | SANDOZ GROUP AG | BLPLD38 | 44.97 | 22,230 | 999,753.08 |
1.40 | DXCM | DEXCOM INC | B0796X4 | 72.10 | 12,228 | 881,638.80 |
1.35 | UTHR | UNITED THERAPEUTICS CORP | 2430412 | 349.71 | 2,427 | 848,746.17 |
1.34 | PODD | INSULET CORP | B1XGNW4 | 233.37 | 3,612 | 842,932.44 |
1.29 | 3692 HK | HANSOH PHARMACEU | BJYKB72 | 2.66 | 306,643 | 814,710.95 |
1.24 | GMAB DC | GENMAB A/S | 4595739 | 229.48 | 3,413 | 783,203.53 |
1.21 | INCY | INCYTE CORP | 2471950 | 65.69 | 11,578 | 760,558.82 |
1.13 | DVA | DAVITA INC | 2898087 | 157.05 | 4,522 | 710,180.10 |
1.03 | EXAS | EXACT SCIENCES CORP | 2719951 | 69.35 | 9,372 | 649,948.20 |
1.03 | SN/ LN | SMITH & NEPHEW PLC | 0922320 | 14.32 | 45,171 | 646,732.34 |
1.01 | COH AU | COCHLEAR LTD | 6211798 | 187.98 | 3,379 | 635,178.82 |
1.00 | FME GR | FRESENIUS MEDICAL CARE AG | 5129074 | 41.54 | 15,158 | 629,711.15 |
0.95 | NBIX | NEUROCRINE BIOSC | 2623911 | 116.20 | 5,129 | 595,989.80 |
0.91 | TFX | TELEFLEX INC | 2881407 | 236.63 | 2,426 | 574,064.38 |
0.84 | OHI | OMEGA HEALTHCARE | 2043274 | 41.57 | 12,658 | 526,193.06 |
0.74 | PHM SM | PHARMA MAR SA | BMW2GT8 | 80.76 | 5,746 | 464,048.83 |
0.71 | EXEL | EXELIXIS INC | 2576941 | 28.50 | 15,584 | 444,144.00 |
0.70 | ENSG | ENSIGN GROUP INC/THE | B1YWPP8 | 151.87 | 2,912 | 442,245.44 |
0.69 | DEMANT DC | DEMANT A/S | BZ01RF1 | 37.86 | 11,536 | 436,744.68 |
0.55 | AMP IM | AMPLIFON SPA | B14NJ71 | 29.89 | 11,660 | 348,536.04 |
0.54 | GKOS | GLAUKOS CORP | BYMWL19 | 134.08 | 2,543 | 340,965.44 |
0.53 | YPSN SW | YPSOMED HOLDING AG-REG | B02SWN8 | 471.79 | 703 | 331,668.88 |
0.52 | HALO | HALOZYME THERAPEUTICS INC | 2975098 | 50.46 | 6,535 | 329,756.10 |
0.45 | MMSI | MERIT MEDICAL SYSTEMS INC | 2580555 | 95.31 | 2,981 | 284,119.11 |
0.43 | MNKD | MANNKIND CORP | BF081J4 | 6.82 | 39,575 | 269,901.50 |
0.41 | BPMC | BLUEPRINT MEDICINES CORP | BWY52P3 | 82.77 | 3,149 | 260,642.73 |
0.41 | AGIO | AGIOS PHARMACEUTICALS INC | BCBVTX1 | 46.08 | 5,559 | 256,158.72 |
0.39 | DNLI | DENALI THERAPEUTICS INC | BD2B4V0 | 27.78 | 8,880 | 246,686.40 |
0.37 | SBRA | SABRA HEALTH CAR | B5NLBP6 | 19.07 | 12,344 | 235,400.08 |
0.36 | NHC | NATIONAL HEALTHCARE CORP | 2139731 | 120.22 | 1,895 | 227,816.90 |
0.35 | SIA CN | SIENNA SENIOR LIVING INC | BWTYXH4 | 12.58 | 17,539 | 220,633.01 |
0.35 | ITGR | INTEGER HOLDINGS CORP | BD06LM7 | 127.93 | 1,721 | 220,167.53 |
0.35 | NHI | NATL HEALTH INVESTORS INC | 2626125 | 75.67 | 2,889 | 218,610.63 |
0.35 | EMBC | EMBECTA CORP | BMXWYR1 | 14.13 | 15,456 | 218,393.28 |
0.33 | CSH-U CN | CHARTWELL RETIRE | B8S8C94 | 11.14 | 18,561 | 206,789.58 |
0.32 | NVCR | NOVOCURE LTD | BYSS4X4 | 16.62 | 12,048 | 200,237.76 |
0.31 | 853 HK | MICROPORT SCIENTIFIC CORP | B676TW7 | 0.90 | 219,602 | 196,933.46 |
0.30 | LTC | LTC PROPERTIES INC | 2498788 | 35.94 | 5,290 | 190,122.60 |
0.30 | 8086 JP | NIPRO CORP | 6641599 | 9.17 | 20,649 | 189,261.73 |
0.30 | RYM NZ | RYMAN HEALTHCARE LTD | 6161525 | 2.99 | 63,184 | 188,904.44 |
0.29 | 2186 HK | LUYE PHARMA GROUP LTD | BNQ4GF3 | 0.38 | 472,624 | 181,210.13 |
0.28 | AED BB | AEDIFICA | B1G5XP1 | 65.56 | 2,731 | 179,045.16 |
0.28 | AMED | AMEDISYS INC | 2024332 | 95.49 | 1,844 | 176,083.56 |
0.27 | 1302 HK | LIFETECH SCIENTIFIC CORP | BV9FKS0 | 0.23 | 746,392 | 170,937.53 |
0.27 | LIVN | LIVANOVA PLC | BYMT0J1 | 53.16 | 3,144 | 167,135.04 |
0.27 | TBPH | THERAVANCE BIOPHARMA INC | BMNDK09 | 8.77 | 19,038 | 166,963.26 |
0.26 | BKD | BROOKDALE SR | B0PZN33 | 6.31 | 25,533 | 161,113.23 |
0.25 | 1789 HK | AK MEDICAL HOLDINGS LTD | BFD6SZ0 | 0.63 | 248,389 | 156,275.78 |
0.24 | OTHER PAYABLE & RECEIVABLES | 1.00 | 148,345 | 148,344.84 | ||
0.24 | GN DC | GN STORE NORD A/S | 4501093 | 19.07 | 7,771 | 148,229.46 |
0.23 | EKTAB SS | ELEKTA AB-B SHS | B0M42T2 | 6.33 | 23,276 | 147,364.93 |
0.23 | ACAD | ACADIA PHARMACEU | 2713317 | 14.74 | 9,776 | 144,098.24 |
0.22 | ALEC | ALECTOR INC | BJ4LDC4 | 5.07 | 27,243 | 138,122.01 |
0.19 | 9229 JP | SUNWELS CO LTD | BNTYNB5 | 11.38 | 10,679 | 121,539.96 |
0.16 | 145720 KS | DENTIUM CO LTD | BF07GJ6 | 55.02 | 1,801 | 99,087.51 |
0.14 | AGL | AGILON HEALTH INC | BLR4TK4 | 2.70 | 31,921 | 86,186.70 |
0.10 | ATEC | ALPHATEC HOLDINGS INC | BD60BG7 | 5.27 | 12,139 | 63,972.53 |
0.08 | 2500 HK | VENUS MEDTECH -H | BL6V047 | 0.47 | 102,940 | 48,382.05 |
0.00 | RADIUS HEALTH INC - CVR | 2KFF9T0 | 0.00 | 19,104 | 0.02 | |
0.00 | CANADIAN DOLLAR | 1.00 | 0 | -0.01 | ||
0.00 | DANISH KRONE | 0.15 | -308 | -44.68 | ||
0.00 | SWISS FRANC | 1.15 | -1,261 | -1,456.74 | ||
-0.01 | EURO | 1.08 | -2,869 | -3,103.80 | ||
-0.03 | CASH | 1.00 | -17,865 | -17,864.87 |
Sector | Weight (%) | |
---|---|---|
Health Care | 92.0 | |
Real Estate | 8.1 |
Industry | Weight (%) | |
---|---|---|
Pharmaceuticals, Biotechnology & Life Sciences | 48.3 | |
Health Care Equipment & Services | 39.2 | |
Equity Real Estate Investment Trusts (REITs) | 8.1 | |
Pharmaceuticals, Biotechnology | 4.4 |
Country | Weight (%) | |
---|---|---|
United States | 52.2 | |
Switzerland | 12.0 | |
Japan | 8.2 | |
Denmark | 4.8 | |
Britain | 4.8 | |
China | 4.6 | |
Belgium | 3.2 | |
Ireland | 2.9 | |
South Korea | 2.7 | |
Australia | 1.1 | |
Germany | 1.0 | |
Other | 2.5 |
All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.
Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.
Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.
Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.
Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.
AGNG traded under the ticker LNGR from inception until April 1, 2021.